Table 1 Characteristics of reported cases and antibodies used for immunohistochemistry
From: Localized amyloidosis of the epididymis: a previously unreported phenomenon
Case | Age (years) | Presentation and resulting diagnosis | Larger diameter (cm) | Contralateral epididymal exploration | Operation | Follow-up (months) | IHC Primary antibodies used |
|---|---|---|---|---|---|---|---|
1 | 77 | Nodule in the left epididymis Result: Epididymal amyloidosis | 1.4 | Thickened | Nodule removal | 48 (Free of disease) | Light chain λ Dako [D: 1:50] Light chain κ Dako [D: 1:50] Transthyretin Dako [D: 1:600] Amyloid P Abcam [D: 1:50] Amyloid A Dako [D: 1:50] CK AE1 AE3 Dako [D: 1:100] EMA Dako [D: 1:100] CD68 Dako [D: 1:100] CD34 Dako [D: 1:50] αSMA Dako [D: 1:50] |
2 | 72 | Nodule in the right epididymis Result: Epididymal amyloidosis | 1.6 | NED | Nodule removal | 9 (Free of disease) | |
3 | 67 | Left scrotal swelling for 4 years. Physical examination: a firm, non-reducible mass. Result: Paratesticular liposarcoma and Epididymal amyloidosis without tumour involvement | 0.7 (size refers only to epididymal amyloidosis) | NA | Radical Orchiectomy | NA |